2.12.24 Mass Vaccinations For The Pandemic Control of COVID-19 is a Failed Doctrine
Source: Awaken India Movement Volunteer (RG)
Reference: London Center For Policy Research
With all of the approved mRNA “vaccines” now showing clear signs of failure, the FDA has desperately reversed its banned practice of administering a mRNA booster dose that is a different from the type of mRNA vaccine used for an individual’s primary vaccination. The FDA justification for this is a recent NIH review of the data from a small 458 volunteer cohort.26 This rushed, incomplete study represents “junk” science and it is suggestive of a state of desperate panic at the NIH, FDA and CDC, to keep the mRNA vaccines in play.
Enough is enough and it is time to face the truth;
With the present mRNA vaccines, there is no all-encompassing positive Benefit over Risk for vaccinating children in the 5 to 11 age group for COVID-19. There is no way to know if a vaccinated child with comorbidities will have a higher risk for adverse events if they later catch COVID-19 from a mRNA “vaccine” that does not work well. Known comorbidities associated with an increased COVID-19 risk include obesity, diabetes, chronic lung disease, sickle cell disease, or immunosuppression. Again, this is for a child’s physician to carefully decide.
It must be remembered that this possibility is evidenced by the irrefutable fact that the countries with the highest COVID-19 “vaccination” rates, are now showing the highest increases in COVID-19 cases.27 The COVID mRNA “vaccines” are not working reliably.
It is now past time for the Government Accountability Office as well as a specially-designated Senate Committee with a panel of outside advisors, to be formed to investigate the actions and motives from January 2020 to date, concerning the decisions made by Dr. A. Fauci at the NIH and the conflict-of-interest ridden CDC Advisory Committee on Immunization Practices (ACIP).
Particular attention should be given to Dr. Stephen Hahn (the 2020 FDA Commissioner and Dr. Janet Woodcock (the current temporary FDA Commissioner who earlier recused herself from all vaccine decisions because of her conflicts-of-interest.)
Both these individuals played a major role in blocking the use of hydroxychloroquine for early-stage COVID-19 in outpatients.
In addition, some of the 20 members of the FDA Vaccines and Related Biological Products Advisory Committee (FDA/ VRBPAC) need a close examination for conflicts-of-interest and openly cleared of any possible role in the subversion of the proven safe, cheap, and effective early outpatient treatments for COVID-19 and the replacement of this doctrine with an ill-advised, mass vaccination program involving highly experimental mRNA and DNA Biological Products.
(Sub-references available inside the aforementioned reference link)
